Nobipharmsp. z o.o.

Other professional, scientific and technical activities not elsewhere classified

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2002-04-23
Share capital
50 000,00 PLN
Activity description

Nobipharm is a pharmaceutical wholesaler that offers medicinal products in therapeutic areas such as immunoglobulins, albumins, intensive therapy, and hemophilia. The company also provides medical devices and diagnostic equipment.

Registered address
Rydygiera 8, 01-793 Warszawa, Poland
Website
nobipharm.pol.plWebsite active
Email
Email warning
Electronic delivery address
AE:PL-77499-24171-JSSGC-15

Financials

The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue
This companyUSD 9.45mMedianUSD 65.87kAverageUSD 537.55k
Net profit
This companyUSD 1.36mMedianUSD 1.97kAverageUSD 12.16k
Operating costs
This companyUSD 7.65mMedianUSD 53.55kAverageUSD 458.91k
Assets
This companyUSD 5.12mMedianUSD 59.69kAverageUSD 1.36m

Bank accounts

Registered as a VAT taxpayer on 1996-01-01. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

10 public aid cases recorded, with a total value of $400,785.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$17,288
De minimis aid (in accordance with Commission Regulation 2023/2831)
$32,145
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$12,027

Tenders

386 tenders recorded as contractor: 83 national ($2,490,202) and 303 EU ($576,008,209).

SubjectAmount
Dostawa leków różnych i płynów infuzyjnych oraz leków programowych
—
Dostawa produktów leczniczych różnych dla SPZOZ w Sanoku
—
„Dostawa produktów leczniczych, leków w ramach programów lekowych oraz wyrobów medycznych”
—

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Tomasz Jerzy Nowak — General Director

Manner of representation

The President of the Management Board – General Director – independently; in the event of the appointment of a multi-member management board, the President of the Management Board – General Director – independently, two members of the management board jointly, a member of the management board jointly with a commercial proxy, or two commercial proxies jointly.

Ownership

OwnerSharesShare valueStake
Krzysztof Nowak (42)
330$4,457.0533%
Tomasz Jerzy Nowak (76)
670$9,049.1667%

Tomasz Jerzy Nowak and Krzysztof Nowak hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person
Krzysztof Nowak (42)
Tomasz Jerzy Nowak (76)

Competitors

Name
Polska Sieć Handlowa LivioS.A.
Bernas Engineeringsp. z o.o.
Dolnośląski Park Innowacji i NaukiS.A.
Rateart Dariusz Matyjewiczsp. k.
EIT Food Clc North-Eastsp. z o.o.
Agriportsp. z o.o.
Reeko Organizacja Odzysku OpakowańS.A.
ABC Expertssp. z o.o.
VoltraS.A.
Stars4brandssp. z o.o.

Change history

DateEvent
2006-01-19Share capital change
2003-03-03Share capital change
2002-04-23Entered in the register

FAQ

Last updated: 2026-04-04